The methods for measuring cyber risk have evolved in recent years, but they still skew technical and narrow — truly effective cyber ratings must be holistic assessments...
Five years from now, the Food and Drug Administration expects it will be clearing 10 to 20 cell and gene therapy products a year. Yet while the arrival of gene therapy’s...
Mainframes are designed for efficiency and allow your enterprise to run complex computations in a compact structure. Despite mainframes’ staying power, the customers...
Dave Gruber, Senior Analyst at ESG, takes a closer look at the challenges that organizations face today around vulnerability management and remediation and dive into how...
Every year, enterprises spend millions on security technology and training — only to be caught on the hamster wheel of responding to incidents caused by recurrent...
​With the recent push to adapt to remote and hybrid working environments, enterprises have been challenged to accelerate their digital transformation. The effect has...